Pseudomonas aeruginosa
% high level resistance to ceftazidime by hospital
All clinical specimens
(January-June 2002)

WARDS
Hospital
Isolates
tested
% NS
% R
%I
GR044
1
 
 
 
GR051
39
5,13%
5,13%
0,00%
GR038
17
5,88%
5,88%
0,00%
GR015
97
10,31%
7,22%
3,09%
GR008
19
10,53%
10,53%
0,00%
GR026
44
11,36%
0,00%
11,36%
GR018
50
12,00%
8,00%
4,00%
GR033
74
12,16%
9,46%
2,70%
GR046
8
12,50%
12,50%
0,00%
GR048
15
13,33%
13,33%
0,00%
GR022
57
14,04%
10,53%
3,51%
GR027
33
18,18%
15,15%
3,03%
GR013
27
18,52%
14,81%
3,70%
GR049
15
20,00%
6,67%
13,33%
GR005
71
21,13%
16,90%
4,23%
GR032
21
23,81%
9,52%
14,29%
GR004
29
24,14%
17,24%
6,90%
GR007
59
25,42%
23,73%
1,69%
GR043
31
25,81%
16,13%
9,68%
GR050
151
26,49%
17,88%
8,61%
GR014
264
26,52%
22,35%
4,17%
GR040
229
26,64%
25,33%
1,31%
GR012
37
27,03%
16,22%
10,81%
GR042
33
27,27%
12,12%
15,15%
GR039
174
33,91%
27,01%
6,90%
GR001
25
36,00%
24,00%
12,00%
GR030
136
38,97%
33,82%
5,15%
GR047
154
46,10%
42,86%
3,25%
Grand Total
1910
25,76%
20,89%
4,87%
  
 
 
 
 
Hospital Mean
 
21,23%
15,72%
5,51%
    
ICU
Isolates
tested
% NS
%R
%I
1
 
 
 
 
 
 
 
 
 
 
 
4
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
36
52,78%
44,44%
8,33%
2
 
 
 
3
 
 
 
22
77,27%
72,73%
4,55%
6
33,33%
16,67%
16,67%
1
 
 
 
10
30,00%
10,00%
20,00%
16
37,50%
18,75%
18,75%
 
 
 
 
 
 
 
 
13
53,85%
38,46%
15,38%
6
83,33%
66,67%
16,67%
 
 
 
 
136
69,12%
66,91%
2,21%
119
72,27%
70,59%
1,68%
11
54,55%
36,36%
18,18%
 
 
 
 
119
44,54%
38,66%
5,88%
7
42,86%
42,86%
0,00%
44
65,91%
52,27%
13,64%
33
57,58%
54,55%
3,03%
589
59,76%
53,99%
5,77%
 
 
 
 
 
55,35%
44,99%
10,35%